Neuropsychiatric Symptoms of Movement Disorders

- Depression, Apathy, Anhedonia, Fatigue in Parkinson's Disease

- Mild Cognitive Impairment in Parkinson's Disease

- Parkinson's Disease Dementia

- Impulse Control Disorders

- Influence of Dietary Constituents on Motor and Non-Motor Symptoms in Parkinson's Disease

- Psychosis in Parkinson's Disease

- Neuropsychiatric Manifestations in Atypical Parkinsonian Syndromes

- Neuropsychiatric Disturbances in Dystonia

- Depression in Huntington's Disease

- Cognitive Impairment and Dementia (Mild or Major Neurocognitive Disorder) in Huntington's Disease

- Tics

- Wilson's Disease

- Ataxia

Heinz Reichmann MD PhD graduated from the University of Freiburg, Germany in 1979. He spent the following four years as a research fellow at the Institute for Biochemistry, University of Konstanz, Germany and the Institute of Neurology, Columbia University, USA. This was paid for by honorary grants for excellency to Dr. Reichmann. He returned to Germany where he held a number of positions at the University of Würzburg, becoming Professor of Neurology in 1990. In 1996, he was appointed Chairman of the Department of Neurology at the University of Dresden, where he is now also Dean of the Medical Faculty.

Heinz Reichmann is a member of numerous scientific societies including the German Neurological Society, the European Neurological Society, the American Academy of Neurology, the Royal Society of Medicine and the Movement Disorder Society. In addition, Dr Reichmann serves on the editorial boards for a number of prestigious neurology journals. His major research interests are energy metabolism, neuroprotection, premotor symptoms in Parkinson's disease, etiopathogenesis and treatment in PD. He serves on many Neurological Boards and was President of the German Parkinson Society and the German Muscle Society. In 2009 Professor Reichmann started his 2-year term as President of the German Neurological Society. He is Past-President of the European Neurological Society and has helped to initiate the new European Academy of Neurology, starting from 2014.

"This book provides a much needed review of the latest clinical recommendations on the diagnosis and treatment of the mood, cognitive, and behavioral abnormalities seen in these disorders. ... This is a valuable resource for clinicians who treat patients with movement disorders. ... It also provides useful strategies that can assist clinicians with choosing appropriate pharmacological therapies, subsequent medication monitoring, and patient counseling, while thoroughly examining the evidence guiding these recommendations." (Melissa Jones, Doody's Book Reviews, June, 2015)